114 related articles for article (PubMed ID: 38484256)
1. Urinary Sphingosine-1-Phosphate as a Biomarker for Bladder Pain Syndrome.
Eggers E; Crouss T; Lipetskaia L; DiSanto M
Urogynecology (Phila); 2024 Mar; 30(3):374-380. PubMed ID: 38484256
[TBL] [Abstract][Full Text] [Related]
2. Serum sphingosine-1-phosphate levels in bladder pain syndrome/interstitial cystitis patients: could it help in diagnosis?
Asi T; Asci A; Altan M; Gudeloglu A; Ergen A
World J Urol; 2020 Oct; 38(10):2577-2581. PubMed ID: 31792578
[TBL] [Abstract][Full Text] [Related]
3. Urine nerve growth factor (NGF) level, bladder nerve staining and symptom/problem scores in patients with interstitial cystitis.
Tonyali S; Ates D; Akbiyik F; Kankaya D; Baydar D; Ergen A
Adv Clin Exp Med; 2018 Feb; 27(2):159-163. PubMed ID: 29521057
[TBL] [Abstract][Full Text] [Related]
4. Urinary ATP may be a biomarker of interstitial cystitis/bladder pain syndrome and its severity.
Wu Y; He Y; Qi J; Wang S; Wang Z
Biomol Biomed; 2024 Jan; 24(1):170-175. PubMed ID: 37819233
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome.
Furuta A; Suzuki Y; Igarashi T; Koike Y; Kimura T; Egawa S; Yoshimura N
Int J Urol; 2019 Jun; 26 Suppl 1():35-40. PubMed ID: 31144750
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
[TBL] [Abstract][Full Text] [Related]
7. Circulating sphingosine-1-phosphate as a prognostic biomarker for community-acquired pneumonia.
Hsu SC; Chang JH; Hsu YP; Bai KJ; Huang SK; Hsu CW
PLoS One; 2019; 14(5):e0216963. PubMed ID: 31091284
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of S1P-induced contractile response in detrusor smooth muscle of rats having cystitis.
Anjum I; Denizalti M; Kandilci HB; Durlu-Kandilci NT; Sahin-Erdemli I
Eur J Pharmacol; 2017 Nov; 814():343-351. PubMed ID: 28882559
[TBL] [Abstract][Full Text] [Related]
9. Clinical characterization of interstitial cystitis/bladder pain syndrome in women based on the presence or absence of Hunner lesions and glomerulations.
Watanabe D; Akiyama Y; Niimi A; Nomiya A; Yamada Y; Sato Y; Nakamura M; Kawai T; Yamada D; Suzuki M; Igawa Y; Kume H; Homma Y
Low Urin Tract Symptoms; 2021 Jan; 13(1):139-143. PubMed ID: 32830459
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of interstitial cystitis/bladder pain syndrome in women with chronic pelvic pain: a prospective observational study.
Cheng C; Rosamilia A; Healey M
Int Urogynecol J; 2012 Oct; 23(10):1361-6. PubMed ID: 22398828
[TBL] [Abstract][Full Text] [Related]
11. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
Liang CC; Lin YH; Hsieh WC; Huang L
Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
[TBL] [Abstract][Full Text] [Related]
12. Assessment of treatment outcomes of interstitial cystitis with hydrodistention and bladder training by O'Leary-Sant Interstitial Cystitis Symptom and Problem Indices.
Huang MC; Hsieh CH; Chang WC; Chang ST; Lee MS
Taiwan J Obstet Gynecol; 2018 Oct; 57(5):718-721. PubMed ID: 30342658
[TBL] [Abstract][Full Text] [Related]
13. Decreased serum concentrations of sphingosine-1-phosphate in sepsis.
Winkler MS; Nierhaus A; Holzmann M; Mudersbach E; Bauer A; Robbe L; Zahrte C; Geffken M; Peine S; Schwedhelm E; Daum G; Kluge S; Zoellner C
Crit Care; 2015 Oct; 19():372. PubMed ID: 26498205
[TBL] [Abstract][Full Text] [Related]
14. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
[TBL] [Abstract][Full Text] [Related]
15. Micronized Palmitoylethanolamide-Polydatin Reduces the Painful Symptomatology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Cervigni M; Nasta L; Schievano C; Lampropoulou N; Ostardo E
Biomed Res Int; 2019; 2019():9828397. PubMed ID: 31828153
[TBL] [Abstract][Full Text] [Related]
16. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
Liu HT; Tyagi P; Chancellor MB; Kuo HC
BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
[TBL] [Abstract][Full Text] [Related]
17. In vivo intrabursal administration of bioactive lipid sphingosine-1-phosphate enhances vascular integrity in a rat model of ovarian hyperstimulation syndrome.
Di Pietro M; Pascuali N; Scotti L; Irusta G; Bas D; May M; Tesone M; Abramovich D; Parborell F
Mol Hum Reprod; 2017 Jun; 23(6):417-427. PubMed ID: 28379469
[TBL] [Abstract][Full Text] [Related]
18. Increased Transient Receptor Potential Melastatin 8 Expression in the Development of Bladder Pain in Patients With Interstitial Cystitis/Bladder Pain Syndrome.
Wu L; Zhang J; Zhou F; Zhang P
Urology; 2020 Dec; 146():301.e1-301.e6. PubMed ID: 33045289
[TBL] [Abstract][Full Text] [Related]
19. Does Obtaining a Diagnosis of Interstitial Cystitis/Bladder Pain Syndrome Improve Symptoms or Quality of Life? A Cross-sectional Questionnaire-Based Study.
Volpe KA; Mandelbaum R; Rodriguez LV; Özel BZ; Rolston R; Dancz CE
Female Pelvic Med Reconstr Surg; 2021 May; 27(5):328-333. PubMed ID: 32304396
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.
Sattler KJ; Elbasan S; Keul P; Elter-Schulz M; Bode C; Gräler MH; Bröcker-Preuss M; Budde T; Erbel R; Heusch G; Levkau B
Basic Res Cardiol; 2010 Nov; 105(6):821-32. PubMed ID: 20652276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
